Corrigendum to "Rational approach to drug discovery for human schistosomiasis" [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140-147].

Autor: LoVerde PT; Departments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA; Pathology and Laboratory Medicine, The University of Texas Health Science Center, San Antonio, TX, USA. Electronic address: loverde@uthscsa.edu., Alwan SN; Departments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA., Taylor AB; Departments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA., Rhodes J; Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio, San Antonio, TX, USA., Chevalier FD; Program in Host-Pathogen Interactions, Texas Biomedical Research Institute, San Antonio, TX, USA., Anderson TJ; Program in Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX, USA., McHardy SF; Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio, San Antonio, TX, USA.
Jazyk: angličtina
Zdroj: International journal for parasitology. Drugs and drug resistance [Int J Parasitol Drugs Drug Resist] 2022 Apr; Vol. 18, pp. 103. Date of Electronic Publication: 2022 Jan 19.
DOI: 10.1016/j.ijpddr.2022.01.003
Databáze: MEDLINE